POH are solidly and consistently moving forward to commercialize a seven day OXYPATCH that is abuse proof and very effective chronic pain treatment.
This will be a world first for opiod drugs and a Blockbuster for POH. We ill own it a 100 percent and the sales potential is a bout 5 billion globally.
Whilst we own it better than 60 % of revenue will flow back to POH coffers. This is a company maker and we are getting very close.
PoS
phosphagenics collaborates with 3m to develop , page-32
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 48 | 86752619 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 59770911 | 19 |
View Market Depth
| Last trade - 07.01am 21/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable